DISEASE INDICATIONS: Psoriasis MANUFACTURER: Boehringer Ingelheim USAGE: Intravenous MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Spevigo (spesolimab-sbzo) is a prescription medication administered through intravenous infusion to treat moderate to severe plaque psoriasis in adults. The medication blocks the protein interleukin-23 (IL-23) to reduce inflammation, improve skin appearance, and slow down disease progression.